Alternatives to Harmony Biosciences Holdings

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Global biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases.

Gene therapy company developing treatments for rare inherited diseases.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Lutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Biopharmaceutical company focused on rare genetic diseases of obesity.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Developing engineered biologics to harness the immune system for disease treatment.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Clinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotech company developing next-generation gene writing tools for advanced therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Biotechnology company developing novel immunotherapies for cancer.

Gene therapy company developing transformative treatments for severe genetic diseases.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Biopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Biotech company focused on developing therapies to extend human healthspan and lifespan.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Develops and manufactures biologics for therapeutic applications.

Global marketplace connecting researchers with human biospecimens for life science research.

Metly empowers pharma companies to accelerate product launches through intelligent opportunity detection and partner matching.

Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

VISEN Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for inflammatory and fibrotic diseases.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

Global healthcare company focused on diabetes care, obesity, and rare blood disorders.

AI-powered platform for antibody discovery and development to create new medicines.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.